Rodney Lappe, Director, Ten Percent Owner at Mirati Therapeutics, holds 133.02K shares in Design Therapeutics (Ticker: DSGN), holds 1.98M shares in Mirati Therapeutics (Ticker: MRTX). Most recently, Rodney Lappe Bought ― shares of Design Therapeutics on Oct 02, 2023 for an estimated value of 49.14K.